Pictured
with
the
Intilume™
System
(from
left)
Professor
Kwok
Ka-wai,
Co-Founder
of
Agilis
Robotics
and
Professor
in
the
Department
of
Mechanical
and
Automation
Engineering
at
CUHK,
Professor
Ng
Chi-fai,
Tzu
Leung
Ho
Professor
of
Urology,
and
Dr
Peter
Chiu
Ka-fung,
Associate
Professor
in
the
Division
of
Urology.
The
trial,
conducted
since
December
2022,
involved
eight
patients
with
bladder
tumours.
All
procedures
achieved
complete
tumour
removal,
and
six
patients
who
completed
30-day
post-surgery
observations
showed
satisfactory
recovery.
Two
patients
remain
under
observation,
with
all
participants
discharged
within
1–2
days.
The
Intilume™
System
The
Intilume™
System
is
a
robotic
surgical
platform
designed
to
improve
precision
and
stability
in
minimally
invasive
procedures.
Featuring
two
dextrous
and
miniaturised
robotic
arms
(2.8mm–3.5mm
in
diameter),
it
enables
accurate
en
bloc
tumour
resections
in
confined
spaces.
Its
intuitive
controls
can
reduce
reliance
on
manual
dexterity,
shorten
the
learning
curve,
and
enhance
outcomes
for
complex
procedures
like
ERBT.
Conventional
resection
loop
used
to
perform
bladder
tumour
resection
(left)
versus
the
pair
of
flexible
robotic
instruments
developed
by
Agilis
Robotics
(right).
Addressing
Bladder
Cancer
Treatment
Challenges
Bladder
cancer
is
among
the
10
most
common
cancers
globally,
with
75%
of
cases
being
non-muscle-invasive.
ERBT
is
more
effective
than
conventional
transurethral
resection
(TURBT)
in
reducing
recurrence
but
requires
high
surgical
expertise
and
carries
bleeding
and
bladder
perforation
risks.
The
Intilume™
System
improves
stability
and
precision,
minimizing
these
risks.
Dr.
Peter
CHIU
Ka-fung,
Associate
Professor
in
CUHK’s
Division
of
Urology,
remarked:
“The
robotic
system
increases
the
stability
of
ERBT
operations,
reducing
the
risks
of
bleeding
and
perforation,
and
enhancing
surgical
precision.
It
helps
lower
the
risk
of
recurrence
due
to
residual
tumour
tissue
and
speed
up
patient
recovery.
Future
Applications
The
Intilume™
System
has
potential
applications
beyond
bladder
cancer,
including
gastrointestinal,
prostate,
uterine,
and
biliary
surgeries.
Its
compatibility
with
standard
endoscopes
and
adaptable
design
makes
it
a
versatile
tool
across
various
specialties.
This milestone underscores Agilis Robotics’ commitment to advancing precision in minimally invasive surgery.
Hashtag: #AgilisRobotics
The issuer is solely responsible for the content of this announcement.
Support InfoStride News' Credible Journalism: Only credible journalism can guarantee a fair, accountable and transparent society, including democracy and government. It involves a lot of efforts and money. We need your support. Click here to Donate